Please login to the form below

Not currently logged in
Email:
Password:

drug development

This page shows the latest drug development news and features for those working in and with pharma, biotech and healthcare.

J&J’s targeted bladder cancer treatment gets US approval

J&J’s targeted bladder cancer treatment gets US approval

FGFRs regulate important biological processes including cell growth and division during development and tissue repair. ... patients in close consultation with the FDA," said Peter Lebowitz, Global Therapeutic Area Head, Oncology, Janssen Research

Latest news

More from news
Approximately 21 fully matching, plus 794 partially matching documents found.

Latest Intelligence

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    Its high prices are controversial, but Vertex also embodies the best of biopharma drug development. " />. ... Ex-Merck &Co. scientist Joshua Boger did want the company to pioneer rationale drug discovery and development, however, and after.

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    How past failures and emerging biology are reshaping drug development. " />. How past failures and emerging biology are reshaping drug development. Over the past 15 years, the best-resourced drug development teams ... AC Immune and its partners are far

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    advanced (phase 3) trials, EPAD aims to accelerate the development of effective therapies. ... commercial drug development.

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    With its potential in drug development, personalised medicine and transforming patient outcomes, the study of the human genome could address some of life sciences’ biggest challenges, including rising healthcare costs. ... This will result in the

  • Bringing life to precision medicine Bringing life to precision medicine

    Thus far, researchers have been unable to identify which cancer drug will work most effectively for specific patients, ie, precision medicine. ... From treatment identification to drug development. Organoids can also advance our understanding of drug

More from intelligence
Approximately 6 fully matching, plus 108 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    I am delighted to welcome Frank to the team at this exciting stage in the company’s development. ... The combination of his strong experience in regulatory affairs, not only with the FDA but on a broad international basis with a proven track record and

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Dr. Rickard’s extensive expertise in respiratory drug development, combined with her strong leadership skills will be a tremendous asset as we prepare for the pivotal phase 3 clinical development programme ... Prior to joining Verona Pharma, she was a

  • New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

    Mader brings a track record of drug discovery experience to the biotech, most recently working for Eli Lilly, where she contributed to the development of multiple clinical candidates. ... Meanwhile, Mahesh Padval also joins Relay as senior vice president

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries. ... Atkins said: “Britten joins our Senior Management team at a pivotal time in the Company’s development.

  • Pharma industry appointments Pharma industry appointments

    activities and continues to advance its lead drug candidate, XF-73, through clinical development.”. ... Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28

More from appointments
Approximately 1 fully matching, plus 170 partially matching documents found.

Latest from PMHub

  • World AIDS Day 2018: Fighting the stigma surrounding HIV

    8. In order to prevent the development of drug resistance, the World Health Organization recommends that at least three antiretroviral drugs are prescribed in combination:. ... Available at: . Accessed November 2018. The history of vaccines. The

  • Practical Patient Centricity

    3. Drug development costs can be reduced. Patient-derived data drives the development of medicines. ... Patients frequently are not forthcoming with their experiences of a condition, with the potential loss of valuable data that could improve a

  • Putting the patient first

    You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch.

  • Big data, privacy and the rise of genomic testing

    to scientists in academia and drug development. ... This will help inform and progress healthcare from drug discovery,  to diagnosis and treatment choice.

  • How do you define a biotech company?

    Another financial website  thestreet.com  defines biotech as a development-stage company in the life science space. ... There are numerous examples of long-term dedication to drug development in pharma – take Lilly’s 30-year dedication to

More from PMHub
Approximately 0 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics